INDEX PHARMACEUTICALS HOLDING AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.37 SEK | +0.54% |
|
+6.02% | +44.53% |
| 04-26 | InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-05 | Index Pharmaceuticals Holding AB Announces Board Resignations | CI |
Chart calendar InDex Pharmaceuticals Holding AB
d1e5f.RDzQcuClENh_ULpuIwMNtSp1_IGzOriysPjRLtVzzi0.K3KBQpnhW-oxfdUjR2RVxGQhrfaLU_7W5bPiWY1EiH99aJwRlu51tk5i8w~13a0f68b51def8008b3e45d35f58bbdc
Upcoming events on InDex Pharmaceuticals Holding AB
Past events on InDex Pharmaceuticals Holding AB
| 27/02/2024 | Investor Update Webinar |
| 20/02/2024 | Q4 2023 Earnings Release |
| 27/11/2023 | Q3 2023 Earnings Release |
| 22/11/2023 14:00 | Business Update Call |
| 15/10/2023 09:30 | United European Gastroenterology Week |
| 02/10/2023 | Redeye Autoimmune and Inflammatory Disease Conference |
| 31/08/2023 05:00 | HC Andersen Capital Life Science Seminar |
| 22/08/2023 | Q2 2023 Earnings Release |
| 01/06/2023 14:00 | Business Update Call - License Agreement |
| 01/06/2023 05:00 | Redeye Growth Day |
| 23/05/2023 | Annual General Meeting |
| 23/05/2023 | Q1 2023 Earnings Release |
| 09/05/2023 12:00 | Business Update Call |
| 28/02/2023 | European Crohn and Colitis Organisation Congress |
| 22/02/2023 | FY 2022 Earnings Release |
| 22/11/2022 | Q3 2022 Earnings Release |
| 07/10/2022 | United European Gastroenterology Conference |
| 25/08/2022 | Interim 2022 Earnings Release |
| 01/06/2022 16:00 | Annual General Meeting |
| 20/05/2022 | Digestive Disease Week Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,09 0,00 - | 0,04 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 97,5 105 -7.14% | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | -86,8 -64,0 -35.58% | -56,2 -75,0 25.12% | -102 -98,1 -3.61% | -102 -176 42.1% | -106 -61,0 -74.02% | -257 |
|
EBIT Million SEK | Released Forecast Spread | -87,7 -64,0 -37.03% | -57,3 -76,0 24.54% | -103 -99,4 -3.56% | -103 -178 41.87% | -107 -63,0 -70.42% | -258 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -87,8 -64,0 -37.15% | 0,00 0,00 - | -103 -99,3 -3.75% | -100 -178 43.52% | -95,3 -49,0 -94.42% | -259 |
|
Net income Million SEK | Released Forecast Spread | -87,8 -64,0 -37.19% | 0,00 0,00 - | -103 -99,3 -3.75% | -100 -178 43.52% | -95,3 -172 44.46% | -259 |
|
EPS SEK | Released Forecast Spread | -1,19 -0,72 -65.28% | 0,00 0,00 - | -0,21 -0,32 34.38% | -0,19 -0,30 36.67% | -0,18 -0,32 43.75% | -0,49 |
| Announcement Date | 20/02/20 | 25/02/21 | 23/02/22 | 23/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q3 |
|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 |
|
Net income Million SEK | Released Forecast Spread | -37,9 |
|
EPS SEK | Released Forecast Spread | -0,07 |
| Announcement Date | 28/11/23 |
More events
Past sector events for InDex Pharmaceuticals Holding AB
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INDEX Stock
- Calendar InDex Pharmaceuticals Holding AB
